Axe Compute Cash Flow from Financial Activities 2012-2026 | AGPU
Axe Compute cash flow from financial activities from 2012 to 2026. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
|
Axe Compute Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $52 |
| 2024 | $4 |
| 2023 | $0 |
| 2022 | $7 |
| 2021 | $50 |
| 2020 | $13 |
| 2019 | $9 |
| 2018 | $6 |
| 2017 | $5 |
| 2016 | $2 |
| 2015 | $12 |
| 2014 | $3 |
| 2013 | $4 |
| 2012 | $1 |
| 2011 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.022B | $0.000B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |